Details for 2017168752

Up to date per 01.04.2026

Actions

Title / Product Name

ZUR BEHANDLUNG VON ABNORMEM ZELLWACHSTUM BEI SÄUGETIEREN GEEIGNETE KRISTALLINE FORMEN VON 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOL

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017168752

EP Publication Number

3252047

E-Number

1491346

Language

PCT Number

Publication Date

06.12.2017 A

11.05.2022 B1

Registration Date

11.05.2022

AT Publication Date

15.05.2022

Application Date

25.03.2008

Registration Number

Priorities

05.04.2007

910379 P

01.10.2007

976546 P

26.02.2008

31554

IPC

C07D 401/06 20060101AFI20180705BHEP

Maximum Duration of Protection

25.03.2028

Owner

Pfizer Products Inc.Eastern Point Road Groton, CT 06340US

Representative

No representatives present

Inventor

CAMPETA, Anthony, MichaelPfizer Global Research & Development Eastern Point Road Groton, CT 06340US

CHEKAL, Brian, PatrickPfizer Global Research and Development Eastern Point Road Groton, CT 06340US

MCLAUGHLING, Robert, WilliamPfizer Global Research and Development Eastern Point Road Groton, CT 06340US

SINGER, Robert, AlanPfizer Global Research and Development Eastern Point Road Groton, CT 06340US